Anterior proliferative vitreoretinopathy in a patient with Coats disease.

作者信息

Kase Satoru, Mori Shohei, Noda Kousuke, Ishida Susumu

机构信息

Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University Sapporo 060-8638, Japan.

出版信息

Int J Ophthalmol. 2018 Feb 18;11(2):343-345. doi: 10.18240/ijo.2018.02.28. eCollection 2018.

DOI:10.18240/ijo.2018.02.28

PMID:29487831

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5824096/

Abstract

摘要

相似文献

Anterior proliferative vitreoretinopathy in a patient with Coats disease.

Int J Ophthalmol. 2018 Feb 18;11(2):343-345. doi: 10.18240/ijo.2018.02.28. eCollection 2018.

Proliferative vitreoretinopathy in Coats' disease. Clinicohistopathological case report.

Ophthalmologica. 1995;209(1):44-6. doi: 10.1159/000310576.

Surgical treatment for chronic hypotony and anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1996 Aug;122(2):228-35. doi: 10.1016/s0002-9394(14)72014-8.

Ultrasound biomicroscopic analysis of anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1998 Dec;126(6):838-9. doi: 10.1016/s0002-9394(98)00225-6.

Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.

Biomark Med. 2013 Oct;7(5):759-67. doi: 10.2217/bmm.13.65.

Pathogenetic mechanisms in anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1992 Sep 15;114(3):257-79. doi: 10.1016/s0002-9394(14)71790-8.

The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease.

Br J Ophthalmol. 2011 Apr;95(4):574-9. doi: 10.1136/bjo.2010.190116. Epub 2010 Nov 21.

Anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1988 Mar 15;105(3):277-84. doi: 10.1016/0002-9394(88)90010-4.

Osseous metaplasia in proliferative vitreoretinopathy.

Am J Ophthalmol. 1998 Apr;125(4):558-9. doi: 10.1016/s0002-9394(99)80201-3.

Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.

Graefes Arch Clin Exp Ophthalmol. 1998 Dec;236(12):900-3. doi: 10.1007/s004170050178.

引用本文的文献

Recent advances in the diagnosis and treatment of Coats' disease.

Int Ophthalmol. 2019 Apr;39(4):957-970. doi: 10.1007/s10792-019-01095-8. Epub 2019 Mar 20.

本文引用的文献

Expression of vascular endothelial growth factor in eyes with Coats' disease.

Invest Ophthalmol Vis Sci. 2013 Jan 7;54(1):57-62. doi: 10.1167/iovs.12-10613.

A case of Coats' disease with visual recovery from no light perception vision after vitrectomy.

Jpn J Ophthalmol. 2011 Jan;55(1):78-80. doi: 10.1007/s10384-010-0897-7. Epub 2011 Feb 18.

Immunopathologic features of inflammatory coats disease.

Arch Ophthalmol. 2005 Feb;123(2):279-81. doi: 10.1001/archopht.123.2.279.

Proliferative vitreoretinopathy in Coats' disease. Clinicohistopathological case report.

Ophthalmologica. 1995;209(1):44-6. doi: 10.1159/000310576.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Anterior proliferative vitreoretinopathy in a patient with Coats disease.

Int J Ophthalmol. 2018 Feb 18;11(2):343-345. doi: 10.18240/ijo.2018.02.28. eCollection 2018.

Proliferative vitreoretinopathy in Coats' disease. Clinicohistopathological case report.

Ophthalmologica. 1995;209(1):44-6. doi: 10.1159/000310576.

Surgical treatment for chronic hypotony and anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1996 Aug;122(2):228-35. doi: 10.1016/s0002-9394(14)72014-8.

Ultrasound biomicroscopic analysis of anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1998 Dec;126(6):838-9. doi: 10.1016/s0002-9394(98)00225-6.

Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.

Biomark Med. 2013 Oct;7(5):759-67. doi: 10.2217/bmm.13.65.

Pathogenetic mechanisms in anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1992 Sep 15;114(3):257-79. doi: 10.1016/s0002-9394(14)71790-8.

The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease.

Br J Ophthalmol. 2011 Apr;95(4):574-9. doi: 10.1136/bjo.2010.190116. Epub 2010 Nov 21.

Anterior proliferative vitreoretinopathy.

Am J Ophthalmol. 1988 Mar 15;105(3):277-84. doi: 10.1016/0002-9394(88)90010-4.

Osseous metaplasia in proliferative vitreoretinopathy.

Am J Ophthalmol. 1998 Apr;125(4):558-9. doi: 10.1016/s0002-9394(99)80201-3.

Substance P in proliferative vitreoretinopathy: the significance of aqueous humor levels for evolution of the disease.

Graefes Arch Clin Exp Ophthalmol. 1998 Dec;236(12):900-3. doi: 10.1007/s004170050178.

引用本文的文献

Recent advances in the diagnosis and treatment of Coats' disease.

Int Ophthalmol. 2019 Apr;39(4):957-970. doi: 10.1007/s10792-019-01095-8. Epub 2019 Mar 20.

本文引用的文献

Expression of vascular endothelial growth factor in eyes with Coats' disease.

Invest Ophthalmol Vis Sci. 2013 Jan 7;54(1):57-62. doi: 10.1167/iovs.12-10613.

A case of Coats' disease with visual recovery from no light perception vision after vitrectomy.

Jpn J Ophthalmol. 2011 Jan;55(1):78-80. doi: 10.1007/s10384-010-0897-7. Epub 2011 Feb 18.

Immunopathologic features of inflammatory coats disease.

Arch Ophthalmol. 2005 Feb;123(2):279-81. doi: 10.1001/archopht.123.2.279.

Proliferative vitreoretinopathy in Coats' disease. Clinicohistopathological case report.

Ophthalmologica. 1995;209(1):44-6. doi: 10.1159/000310576.